Wladysiuk, Magda; Araszkiewicz, Aleksander; Godman, Brian; … - In: Applied Health Economics and Health Policy 9 (2011) 2, pp. 101-110
Market forces appear to drive down the prices of generics and originators as more atypical formulations are launched. However, alternative approaches may be needed if significant co-payment differences compromise individualized care. </AbstractSection> Copyright Adis Data Information BV 2011
